Avoid common mistakes on your manuscript.
Sirs:
An 84-year-old male patient with known ischemic cardiomyopathy was admitted to the emergency department of Leipzig University Hospital with typical signs and symptoms of an acute coronary syndrome in the midst of the SARS-Cov2 pandemic on April 22, 2020. His angina rapidly resolved after angioplasty of a sub-total proximal occlusion of his right coronary artery. However, 12 h later his 81-year-old wife was brought to a secondary care hospital by the emergency doctor because of acute and severe shortness of breath and typical angina. Elevated Troponin, ECG- and echocardiographic abnormalities led to her urgent transfer to our hospital with the suspected diagnosis of acute myocardial infarction .
Her medical history included chronic renal insufficiency and hypertension. Otherwise, the patient was previously well, mobile and in very good general condition. Clinical examination showed an obese woman (163 cm, 97 kg, blood pressure 130/73 mmHg, heart rate 78/min, and body temperature 37.2 °C). The laboratory findings are presented in Table 1.
The 12-lead-ECG at admission displayed a sinus rhythm with a previously known right bundle branch block and new negative T-waves in II, III, aVF and V3-6 (Fig. 1).
Echocardiography (Fig. 2) showed wall motion abnormalities with apical septal dyskinesis, mid ubiquitous akinesia and basal septal and anterior hypokinesis. Left ventricular ejection fraction was reduced to 45%. Global longitudinal strain with a typical strain pattern of apical balloning was −8% (Fig. 3).
Coronary angiogram revealed no signs of artery disease (CAD), as shown in Fig. 4.
Cardiac MR (Fig. 5) showed wall motion abnormalities corresponding to the echocardiography. The tissue characterization by T2STIR sequences documented severe edema (Fig. 6). T1TFE sequences showed diffuse late enhancement. T1- and T2-mapping showed severely increased T1 and T2 values (1660 ms and 68 ms), respectively. Extracellular volume was ~ 37%.
In summary, the findings fulfill the criteria of a Takotsubo (stress) cardiomyopathy [1].
Focused evaluation of potential emotional or physical triggers revealed that the patient suffered from psychologic stress during the last few weeks. Due to media reports, she was highly afraid of SARS-CoV2 infections for her husband and herself, because age and hypertension were communicated as high risk for a severe course of COVID-19. Furthermore, she felt severely affected by the lockdown measures. Her condition acutely and severely exacerbated when her husband was admitted to the hospital, which she felt would place him at a high risk of death, and because she was not allowed to visit him due to the SARS-CoV2-specific regulations.
The patient was provided with psychological support and the SARS-CoV2-negative couple was allowed to meet. Heart failure therapy including an angiotensin receptor blocker, beta blocker, mineraloreceptor antagonist and a loop diuretic was initiated and the symptoms of the patient improved. She was discharged home in stabilized condition.
Two months later, the patient presented to the outpatient clinic. She was asymptomatic and the negative T-waves in II, III and aVF had disappeared (Fig. 7). Echocardiography (Fig. 8) and cardiac MRI showed full recovery of left ventricular function.
Takotsubo (stress) cardiomyopathy (TTS) predominantly affects women. Approximately one-third of the cases are caused by emotional triggers and one-third by physical stress. Typical symptoms are angina pectoris or dyspnea; therefore, myocardial infarction is the most relevant differential diagnosis. Hypo- or akinesis of the apical and mid left-ventricular segments is characteristic. Additional common findings include transient ST-elevations or negative T-waves in ECG and increased Troponin. Increased catecholamine concentrations likely contribute to the pathophysiology that is still incompletely understood [1, 2]. Patients with TTS caused by emotional stress show better long-term outcomes compared with ACS patients or TTS with physical triggers [3].
This case is informative with regard to patient’s perceptions and an example for a collateral medical damage during the SARS-CoV2-pandemic. Collateral damages in this context range from patients avoiding contact to medical professionals despite symptoms, delayed or false diagnoses (because of changes in previously standardized processes) to indirect effects causing psychological and physical diseases [4,5,6]. The fear of infection but also misinformation can cause worsening of preexisting psychological disorders and potentially life-threatening conditions [7,8,9,10]. Careful education of patients at risk and information of the general population appears crucial to prevent these events.
References
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C (2018) International Expert Consensus Document on Takotsubo Syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 39:2032–2046. https://doi.org/10.1093/eurheartj/ehy076
Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschöpe C, Schultheiss H-P, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Böhm M, Erbel R, Cuneo A, Kuck K-H, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KEJ, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Lüscher TF (2015) Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 373:929–938. https://doi.org/10.1056/NEJMoa1406761
Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Münzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimský P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Böhm M, Lüscher TF, Ruschitzka F, Templin C (2018) Long-term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol 72:874–882. https://doi.org/10.1016/j.jacc.2018.06.016
Tang W, Hu T, Hu B, Jin C, Wang G, Xie C, Chen S, Xu J (2020) Prevalence and correlates of PTSD and depressive symptoms one month after the outbreak of the COVID-19 epidemic in a sample of home-quarantined Chinese university students. J Affect Disord. https://doi.org/10.1016/j.jad.2020.05.009
Custodis F, Schwarzkopf K, Weimann R, Spüntrup E, Böhm M, Laufs U (2020) A SARS-Cov2-negative corona victim. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01668-z
Abdi S, Salarifar M, Mortazavi SH, Sadeghipour P, Geraiely B (2020) COVID-19 sends STEMI to quarantine!? Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01664-3
Li G, Li H, Lu J (2020) No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01653-6
Khan S, Siddique R, Li H, Ali A, Shereen MA, Bashir N, Xue M (2020) Impact of coronavirus outbreak on psychological health. J Glob Health 10:10331. https://doi.org/10.7189/jogh.10.010331
DeJong C, Wachter RM (2020) The risks of prescribing hydroxychloroquine for treatment of COVID-19-first. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.1853
Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G (2020) Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMoa2006923
Acknowledgments
Open Access funding provided by Projekt DEAL.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Uhe, T., Hagendorff, A., Wachter, R. et al. Collateral damage: Fear from SARS-CoV2-infection causing Takotsubo cardiomyopathy. Clin Res Cardiol 109, 1588–1594 (2020). https://doi.org/10.1007/s00392-020-01706-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-020-01706-w